You just read:

Seattle Children's Opens First CAR T-Cell Immunotherapy Trial in the U.S. for Children and Young Adults With Leukemia that Targets CD22 and CD19 Proteins Simultaneously

News provided by

Seattle Children’s

Nov 16, 2017, 08:04 ET